PATENT APPLICATION. int. ci.5: A61K 31/035, A61K7/06

Similar documents
Europaisches Patentamt European Patent Office. Publication number: Office europeen des brevets EUROPEAN PATENT APPLICATION

Perm Manual. Evondil Quaternium. Technical Department V.1

RegenScalp The Ultimate Hair Restoration Solution

(12) Patent Application Publication (10) Pub. No.: US 2009/ A1

Main ready-made products list [Quasi drugs] Skin-whitening series Product names Active ingredients Product characteristics

Applicant: Siwoku, Helen Marion Normanton Grange Normanton Avenue Aigburth Liverpool 17 Merseyside(GB) ( Applicant: Siwoku, David

Hair Restoration Gel

TEPZZ 9659Z A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: B32B 17/10 ( )

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

United States Patent (19) Katz

CLINICAL EVALUATION OF REVIVOGEN TOPICAL FORMULA FOR TREATMENT OF MEN AND WOMEN WITH ANDROGENETIC ALOPECIA. A PILOT STUDY

(12) United States Patent (10) Patent No.: US 6,308,717 B1

RootBioTec HO Prevents hair loss ensures fuller hair

Orino a (A Div. of Origo Pharmaceuticals Pvt.Ltd.)

(12) Patent Application Publication (10) Pub. No.: US 2006/ A1

(12) Patent Application Publication (10) Pub. No.: US 2004/ A1

(12) United States Patent

(12) United States Patent (10) Patent No.: US 7434,929 B2

(12) United States Patent

Table of Contents. Marketing Trends Chemical & Physiological Composition of Hair Fision KeraVeg18 Comparisons:

United States Patent (19) Humbrecht

Hair loss, alopecia areata, cicatricial alopecia. By Kai Chi Chan P-year Medical Student SGUL-UNIC at Sheba Hospital

(12) Patent Application Publication (10) Pub. No.: US 2015/ A1

(12) Patent Application Publication (10) Pub. No.: US 2005/ A1

Supplemental January 2009

(12) United States Patent (10) Patent No.: US 6,752,627 B2

Ref. 11. (12) Patent Application Publication (10) Pub. No.: US 2012/ A1. (19) United States. Polstein et al. (43) Pub. Date: Jun.

WORESANA. THE ACTIVE INGREDIENT FROM RYE The patented cosmetic active ingredient from fermented organic rye for sustainable skincare WORESANA

Dr. Khadavi, MD Board Certified Dermatologist Creator of Revivogen

RELAUNCH NEW FORMULA WITH PLANT STEM CELLS NEW DESIGN

Dr. Abbasi Hair Clinic

(12) Patent Application Publication (10) Pub. No.: US 2006/ A1

Introduction on hair loss

(12) United States Patent (10) Patent No.: US 6,422,036 B1. Giannis et al. (45) Date of Patent: Jul. 23, 2002

Addition of Benzylic Bromines to Ethyl Paraben. been found in studies to bind to the estrogen receptors. Because of this binding site, many

The Identification of a Lipstick Brand: A Comparison of the Red Pigment R f Values using Thin Layer Chromatography

(12) (10) Patent No.: US 6,971,424 B1. Angevine (45) Date of Patent: Dec. 6, (54) INTERCHANGEABLE HANDBAG 4,112,991 A 9/1978 Barbaresi...

WWWWW. ( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1. 19 United States

United States Patent (19)

OBSERVATIONS ON THE FLUORESCENT MATERIAL IN HAIRS

HAIR MINERAL ANALYSIS, AN INTRODUCTION by Lawrence Wilson, MD

(12) United States Patent

(12) Patent Application Publication (10) Pub. No.: US 2015/ A1

United States Patent (19)

(12) United States Patent (10) Patent No.: US 6,841,523 B1

The Essence of Beautiful Hair. Keratonics Hair Care Products

(12) United States Patent (10) Patent No.: US 9, B2

TEPZZ 6Z69 ZA_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61M 39/16 ( )

CAPIXYL ANTI-AGING HAIR CARE COMPLEX

The Effects of Shear on Neutralized Carbomers in Aqueous Conditions

HAIR AND SCALP HEALTH

Making you look good is what we do best.

United States Patent (19) Frankel

001 LUMINOX SHINE SHAMPOO

SKIN CONDITIONS. Dehydration, Sensitivity

Tomura, Kazuyo Osaka-shi, Osaka-fu (JP)

About the product: Precautionary measures: Application Instructions

KERATIN CONTAMINATION

United States Patent (19)

EXPERIENCE during the war with the common vesicants, mustard gas. through the skin. After penetration they produce skin reactions

Experience. true. freshness

AnaGain TM Stimulating hair growth and fighting hair loss

COMPLETE SHAMPOO. PRODUCT OVERVIEW: A concentrated and moisturizing premiere cleansing shampoo that delivers thick, creamy lather.

Female pattern hair loss

AnaGain Stimulating hair growth and fighting hair loss

commercial bulleting ALOE HAIR CARE

TRICHOGEN VEG LS 8960

Forensic examination of lipstick by the various physio-chemical and instrumental method.

(12) Patent Application Publication (10) Pub. No.: US 2012/ A1

United States Patent (19) 11 Patent Number: 4,526,488 Krull 45) Date of Patent: Jul. 2, 1985

(12) Patent Application Publication (10) Pub. No.: US 2004/ A1. Reynolds et al. (43) Pub. Date: Jan. 15, 2004

names 1 inch + Black Vis-à-Vis Black Sharpie

(12) Patent Application Publication (10) Pub. No.: US 2014/ A1

AFFINITY - A novel system for direct Intrafollicular infusion of liquid solutions containing active ingredients.

Company & Brand Identity. Educational manual December 2015 Hair products

(12) United States Patent

HTR1, the Amazonian resin. A biomimetic shield for the protection of Hair, Nails and Skin

TAGRAVIT TM R1 Encapsulated pure retinol. March 2015

Redensyl Reactivates hair follicle stem cells for an astonishing hair growth

TECHNICAL INFORMATION

Topical Skin Care L O O K, F E E L A N D L I V E B E T T E R

Vitabrid C¹² FACE. VITABRID C¹² FACE BRIGHTENING Powder

Nimue Core Problematic Core Products Problematic Skin

Conversion of sugarcane by product (filter cake mud) from Savannah sugar company Nigeria, into commercial paste shoe polish

FLORAESTERS CHEMISTRY

PERSONAL CARE. INNOVATIVE & NATURAL Functional ingredients based on sugar chemistry

The Safety and Efficacy of a Sustainable Marine Extract for the Treatment of Thinning Hair

Information PROPECIA Finasteride 1mg Tablet

Cosmetic Chemistry Developed for CWSE-ON 2010

Aqua Keep 10SH-NFC. How to Use Guide

(12) Patent Application Publication (10) Pub. No.: US 2015/ A1

Age Activist. Eyes. Safe and gentle formulas created to target age signs around the eyes.

Made in France - Marque déposée Laboratoires FILORGA - 10 rue de Vézelay Paris Tel. :

CEGABA (carboxyethyl gamma-aminobutyric acid), a molecule derived from polyamines, causes an increase in the proliferation of Hybridomas in vitro.

(12) United States Patent (10) Patent N0.: US 6,257,248 B1 Yeh (45) Date of Patent: Jul. 10, 2001

MIGLYOL 840. Excellent light emollient. Alternative to IPM. INCI: Propylene Glycol Dicaprylate/Dicaprate. Excellent light and dry emollient

AMPOULE ADDITION MASK 900

DON T LET HAIR LOSS TANGLE YOU UP: DERMATOLOGISTS CAN IDENTIFY COMMON HAIR DISORDERS AND OFFER SOLUTIONS

(12) Patent Application Publication (10) Pub. No.: US 2010/ A1

International Journal of Research in Pharmacy and Science

Transcription:

Europaisches Patentamt 19 European Patent Office Office europeen des brevets Publication number : 0 467 660 A2 EUROPEAN PATENT APPLICATION Application number : 91306490.3 int. ci.5: A61K 31/035, A61K7/06 (22) Date of filing : 17.07.91 Priority : 20.07.90 JP 190563/90 @ Inventor : Miyauchi, Yutaka 09.07.91 JP 168268/91 5-9, Shigota-machi Takasaki-shi, Gunma-ken (JP) (43) Date of publication of application : 22.01.92 Bulletin 92/04 @ Representative : Perry, Robert Edward et al GILL JENNINGS & EVERY 53-64 Chancery Lane Designated Contracting States : London WC2A 1HN (GB) DE FR GB Applicant : Miyauchi, Yutaka 5-9, Shigota-machi Takasaki-shi, Gunma-ken (JP) Use of d-limonenes as testosterone-5-alpha-reductase inhibitor and as hair grower. A 5a-reductase inhibitor according to the invention comprises d-limonene, which has an excellent activity inhibitory effect and is highly safe without any drawback as noted by side effects and thus is a suitable component for a hair grower. CM < O CO CO h- co LU Jouve, 18, rue Saint-Denis, 75001 PARIS

Background of the Invention 1. Field of Industrial Application 5 The present invention relates to a testosterone 5a-reductase (hereinafter designated simply as "5a-reductase") inhibitor and a hair grower comprising the same. 2. Description of the Prior Art w Recently, increased numbers of studies have been made on a 5a-reductase inhibitor as a hair grower, and there have been many patent applications for hair growers featured by the effect of preventing loss of hair by inhibition of 5a-reductase (for example, Japanese Patent Laid-open Nos. 53,417/1984 and 53,419/1984). According to a certain view, it is considered that physiological symptoms of, for example, male pattern baldness, psilosis, or seborrhea are caused by an increased hormonal stimulus of androgen, which results from 15 excessive accumulation of the androgenic hormone (5a-dihydro- testosterone) in a metabolic system. It is considered that this androgenic hormone is produced from testosterone by a reducing action of 5a-reductase, and, in particular, the androgenic hormone is produced and accumulated in some organs such as hair roots and sebaceous glands due to the action of 5a-reductase. As a result, hair-matrix cell division may be suppressed, leading to involution of the hair roots, and thereby symptoms of alopecia or baldness may be induced. It is there- 20 fore possible to prevent epilation or to promote hair-growth by inhibitory actions on the 5a-reductase. This is the reason why the 5a-reductase inhibitor is used for hair growers. From this point of view, some compounds used for this purpose have been found. However, though they have a high 5a-reductase activity inhibitory ratio, they have drawbacks of producing side effects or causing high irritation to the skin. 25 Summary of the Invention Accordingly, an object of the present invention is to provide a 5a-reductase inhibitor which has no drawback as noted by the side effects and is highly safe. 30 Another object of the present invention is to provide a hair grower having an excellent hair-growth effect upon application to the human scalp. Other objects, features and advantages of the invention will hereinafter become more readily apparent from the following description. 35 Brief Description of the Drawings Fig. 1 is a graph for explaining an enzymatic activity inhibitory ratio of sodium p-glycyrrhetinic acid. Fig. 2 is a graph for explaining an enzymatic activity inhibitory ratio of Duke extract. Fig. 3 is a graph for explaining an enzymatic activity inhibitory ratio of the hair grower of the present inven- 40 tion. Fig. 4 is a graph for explaining an enzymatic activity inhibitory ratio of d-limonene. Fig. 5 is a graph for explaining an enzymatic activity inhibitory ratio of swertiamarin. 45 Description of the preferred Embodiment Example 1 Various effects of the hair grower of the present invention were studied, and the results are explained in the followings. so The present inventor has already disclosed a novel toilet lotion containing components from citrus fruits and other components (Japanese Patent Publication No. 20,123/1989). This toilet lotion is, of course, provided with the ordinary functions of a toilet lotion, e.g., astringent and cleansing effects, dampness, and lubrication of the skin. It has been confirmed that the toilet lotion gives, besides the above ordinary functions, anti-dandruff and antiprustic effects and an effect of preventing the loss of hair when rubbed into the pores of the scalp after 55 shampooing. It has been also confirmed that some people have enjoyed the benefits of the toilet lotion, which not merely restrained the loss of their hair but also positively promoted the growth of their hair. The toilet lotion consists of each extract from the skin of a navel orange [Citrus sinensis L. Osbeck (Rutaceae)], the skin of an iyokan [Citrus iyo Hort. et Tanaka (Rutaceae)], the skin of a hassaku [Citrus hassaku 2

Hort. et Tanaka (Rutaceae)], the skin of a sweet summer orange [Citrus Natsudaidai var. (Rutaceae)], the skin of a lemon, the skin of a mandarin orange, and aloe, all of said extracts being prepared by extracting with sake. The refined oil from the citrus fruits contains d-limonene in the amount of not less than 90% by weight. It is therefore clear that the d-limonene functions as the 5a-reductase inhibitor and thereby contributes to prevention 5 of the loss of hair and to promotion of the growth of hair. The following table shows a formulation of the hair grower (toilet lotion) in a preferred form of the present invention. w Formulation Components % by weight 15 Extract from navel orange [Citrus sinensis L. Osbeck [Rutaceae)] skin 19.75 20 Extract from iyokan [Citrus iyo Hort. et Tanaka (Rutaceae)] skin 14.82 Extract from hassaku [Citrus hassaku Hort. et Tanaka (Rutaceae)] skin 19.75 Extract from sweet summer orange 25 [Citrus Natsudaidai var. (Rutaceae) ] skin 14.82 Extract from lemon skin 14.82 30 Extract from mandarin orange skin 14.81 Extract from aloe 1.23 ph *1: 4.0-6.0 35. Alcohol number 0.9-1.0 *1: determined according to Japanese Standards of Cosmetic 40 Ingredients - General test method - Test for ph. *2: determined according to The Pharmacopoeia of Japan - General test method - Test for alcohol number. 45 The above extracts are all those extracted with sake (first class refined sake) from the skin of each of the above citrus fruits or other materials. A slight variation in the proportion of each of the above components is expected in the stages of manufacturing. It was, however, confirmed that some +5% of the proportion out of the defined range can be tolerated to ensure the same performance and safety of the composition. 50 Application to the Scalp As the symptoms identified by the loss of hair in the pilose regions of the body, especially the head, many sorts are known, such as androgenic alopecia, alopecia areata, and alopecia seborrheica. In this example, however, the hair grower containing as a major component d-limonene, which is the 5a-reductase inhibitor accord- 55 ing to the present invention, was applied to the scalp of dozens of persons irrespective of the sort of alopecia. The results are shown in the following tables. 3

Anti-dandruff effect *1 Excellently Effective Not effective effective Man 36 persons 22 persons 0 person (58 persons) (62.1%) (37.9%) (0%) Woman 10 persons 12 persons 0 person (22 persons) (45.5%) (54.5%) (0%) Total 46 persons 34 persons 0 person (80 persons) (57.5%) (42.5%) (0%) *1: Excellently : Generation of dandruff was not found effective over five days after applying the hair grower Effective: Generation of dandruff was not found over three days but found within five days after applying the hair grower Not effective: Generation of dandruff was found within three days after applying the hair grower Depilation preventive effect *2 Effective Not effective Man 53 persons 5 persons (58 persons) (91.4%) (8.6%) Woman 20 persons 2 persons (22 persons) (90.9%) (9-1%) Total 7 3 persons 7 persons (80 persons) (91.3%) (8.7%) *2: Effective: A degree of advance in loss of hair was decreased after applying the hair grower Not effective: Depilation preventive effect was not found after applying the hair grower

Hair-growth effect *3 Excellently Effective Not effective effective Ma" 5 persons 32 persons 21 persons (58 persons) (8.6%) (55.2%) (36.2%) Woman 10 persons 5 persons 7 persons (22 persons) (45.5%) (22.7%) (31.8%) Total 15 persons 37 persons 28 persons (80 persons) (18.8%) (46.3%) (35.0%) J: Excellently : New hair grew in all hairless portions effective after applying the hair grower Effective : New hair grew in the area larger than two third of hairless portions after applying the hair grower Not effective: No improvement was found in a hairgrowth effect after applying the hair grower As evidenced from the above results, the hair grower of the present invention is excellently effective or affective on the anti-dandruff, prevention of depilation, and hair-growth. Such excellent effect of the hair grower of the present invention may be due to some action of amino acid in the hair grower of the present invention (contained in the amount of 0.2% by weight in the citrus skin and the refined sake). The following is an explanation for the kinds of amino acid contained in 100 ml of the hair grower of the present invention. Aspartic acid 9.84 mg Isoleucine 5.81 mg Threonine 7.61 mg Leucine 11.58 mg Serine 11.76 mg Thyrosin 8.46 mg Glutamic acid 8.14 mg Phenylalanine 7.53 mg Glycine 10.97 mg Lysine 6.93 mg Manine 25.50 mg Histidine 3.00 mg Zystine 1.52 mg Arginine 21.96 mg /aline 8.55 mg Proline 52.22 mg Methionine 2.07 mg Tryptophan 1.12 mg

Example 2 A more detailed experiment was performed on the inhibitory actions of d-limonene on the 5a-reductase activity. As previously mentioned, it is known that testosterone is converted into 5a-dihydrotestosterone 5 (5aDHT) having an androgenic action and thereby expresses physiological activities. 5a-Reductase is present in living bodies and functions as an enzyme which converts testosterone into 5aDHT. Therefore substances capable of impeding the activities of the enzyme will probably be prophylactics for androgenic alopecia. From the above point of view, a system capable of measuring a testosterone 5a-reductase activity was formed, and, using the system, studies were performed on the 5a-reductase inhibitory activities of the hair w grower of the present invention and of the limonene that is a constituent of the hair grower. Two hair growers of the present invention, one aged and another fresh, and d-limonene were subjected to a test. For control groups, Duke extract and sodium p-glycyrrhetinic acid were selected as positive control groups and swertiamarin as a negative control group. The test was performed according to the following methods. 15 Preparation of a crude enzyme solution A Wristar male rat weighing 250-300 g was sacrificed by bleeding, and its prostata was excised. The prostata was cut into fragments under ice-cooling. A 0.1 M HEPES buffer solution (ph: 7.4) containing 0.25 M suc- 20 rose (the buffer solution is hereinafter referred to as buffer solution A) was added to the fragments in the amount three times the wet weight of the fragments. Using a Potter-type homogenizer made of Teflon, the mixture was homogenized. The homogenate was filtered using a stainless mesh of a 200 p. size, and then the filtrate was centrifuged at 3000 rpm (900 xg) for ten minutes. The precipitate was suspended in 2.5 parts of buffer solution A, followed by centrifuging at 3000 rpm for five minutes. The residue recovered was suspended in buffer solution 25 A weighing 0.8 times the wet weight of the fragments to produce a crude enzyme solution. The crude enzyme solution was stored at -70 C. Enzymatic reaction 30 The test sample (less than 10 p\) previously prepared was added to [4-14C]-testosterone (1.5 nmol, 2.85 kbq), NADPH (0.5 nmol), and the enzyme solution (30 p\) cited above. To this was added the buffer solution A to the extent that the total volume became 100 ul, to prepare a reaction liquid. An enzymatic reaction was performed using the reaction liquid at 37 C for two hours. The enzymatic reaction was initiated by removing the reaction liquid from an ice-water-cooled bath to a 37 C warm bath. The enzymatic reaction was terminated 35 by cooling the reaction liquid in ice-water. After completion of the reaction, 400 p\ of n-hexane was added to the liquid, followed by vigorously stirring the mixture to uniformly mix. The uniformly blended mixture was centrifuged at 3000 rpm and a temperature of 4 C for five minutes to obtain a supernatant liquid. 200 p\ of the supernatant liquid partially collected was evaporated under reduced pressure to a solid, to which was added 30 p\ of n-hexane to redissolve. 10 p\ of the liquid mixture collected in part was applied to a thin layer plate of silica 40 gel. After drying, the deposited substance was developed using cyclohexane-ethyl acetate (1:1, v/v). Quantitative determination of reaction product and Enzymatic activity inhibitory ratio measuring method A radiation activity of the developed material on the TLC plate cited above was measured by means of an 45 AMBIS image analyzer. Two spots shown in a chromatogram were subjected to readings of the radiation activities identified by their positions corresponding to testosterone (T) and dihydrotestosterone (DHT) respectively. The rate of conversion of testosterone into dihydrotestosterone was given by: DHT/(T + DHT) x 100% so Defining the conversion rate in the presence of the negative control as 100, a percentage of the conversion rate in the presence of the sample was calculated to determine the degree of the enzymatic activity inhibitory ratio of the sample. 55 Results First, various organic solvents were investigated to seek an eluent that could clearly isolate testosterone from dihydrotestosterone on the TLC plate, and as a result it was confirmed that both materials could be clearly separated independently by the use of the aforementioned developing solvent mixture, cyclohexane-ethyl ace- 6

tate (1:1, v/v). Specifically, on the TLC plate there were the two spots representing respective radiation activities. One spot with a lower Rf value was for testosterone and another spot with a higher Rf value for dihydrotestosterone. The two spots could be thus distinguished. Second, conditions of the enzymatic reaction were studied, and as a result it was confirmed that the reaction 5 at 37 C for two hours was relatively effective for the conversion of testosterone into dihydrotestosterone. In this case, because the liposoluble sample was barely soluble in water, it was mixed with water by shaking at 120 rpm. Further studies were carried out on the kinds of extracting solvents and thin layer plates, and the like. The reaction conditions thus established are as follows: w [4-14C]-testosterone 1.9 nl NADPH 10 ul Enzyme solution 30 p\ Sample 3-10^1 The process was carried out by heating at 37 C for two hours a reaction liquid made up to 100 ml by the 15 addition of a buffer solution, extracting with hexane, and developing by means of TLC. Next, studies were carried out on the inhibitory activities of sodium p-glycyrrhetinic acid and Duke extract, which were used as the positive controls. As shown in Fig. 1 and Fig. 2, the amounts of sodium p-glycyrrhetinic acid and Duke extract exhibiting a inhibitory ratio of 50% are 0.5 mm and 0.75 p\ respectively. Their remarkably high inhibitory activities are thus confirmed. 20 The inhibitory actions on the testosterone 5a-reductase activity of the hair growers of the present invention and of d-limonene, which is a constituent of the hair grower, were studied. As shown in Figs. 3 and 4, either of the test samples can give a considerable high inhibitory effect. Among the hair growers the aged sample gives a higher inhibitory effect than the fresh sample. On the other hand, the negative control swertiamarin has no inhibitory effect as shown in Fig. 5. 25 As explained above, the hair grower containing as a major component the 5a-reductase inhibitor according to the present invention provides an excellent hair-growth effect upon application to the human scalp. The hair grower is very safe in contact with the skin. Also, it can be readily produced from the skin of citrus fruits and hence has the advantages of easy preparation and reduced cost. 30 Claims 1. Use of d-limonene as a testosterone 5a-reductase inhibitor. 35 2. Use of d-limonene as a hair grower. 3. Use of d-limonene for the manufacture of a medicament for use as a hair grower. 4. Use according to any preceding claim wherein the d-limonene is as collected from a refined oil from the 40 skin of a citrus fruit. 5. Use according to claim 4, wherein the citrus fruit is selected from a navel orange [citrus sinensis L. Osbeck (Rutaceae)], an iyokan [citrus iyo Hort. et Tanaka (Rutaceae)], a hassaku [citrus hassaku Hort. et Tanaka (Rutaceae)], a sweet summer orange [citrus Natsudaidai var. (Rutaceae)], a lemon and a mandarin 45 orange. 50 55 7

F I G. I 0.1 0.5 1 Concentration of sample (mm) Sodium fi-glycyrrhetinic acid 8

F I G. 2 Amount of sample (/il/ioltyl reaction components) Duke extract

F I G. 3 100 r f Hair grower (fresh) / / / / / Hair grower (aged) V / i rf i i i i_ 10 Amount of sample (pl/ioltyl reaction components) Hair grower 10

F I G. 5 ' 1 I III* L_ 0.5 1 Concentration of sample (mm) Swertiamarin 12